To enjoy all the benefits of our website
Phil Whitaker is a GP and the New Statesman’s medical editor. His books include Chicken Unga Fever: Stories from the Medical Frontline (Salt)
The race to provide Covid-19 protection is on, but halting. The vulnerable will need to maintain their guard for a good while yet.
In July, scientific advisers warned of the potential for a significant coronavirus variant to occur in the winter. But instead of preparing for the worst, the government created the ideal conditions for the virus to mutate – and thrive.
The New Statesman’s medical columnist describes his experiences as a GP in the face of Covid-19, as a rumour grew to a distant threat and then to the remarkable challenge of a global pandemic
My mentor, Peter Tate, dedicated his career to changing the poor culture of communication in medicine in the 1970s.
The UK is set to obtain sufficient quantities to begin immunising the 20 million most vulnerable people before the end of the year, but there are logistical problems ahead.
We work through the different categories of pathology - infection, malignancy, metabolic ect, - that underlie all disease.
I groaned inwardly when the results of Jeremy's MRI scan came through: a couple of “indeterminate” areas. Not the definitive all clear I’d hoped for.
At this stage, the duration of the condition is as uncertain as what underlies it.
One of my patients came to realise the extent to which his emotional life was affecting his body.
A study found around 100 symptoms the virus may cause, but only a dozen or so are widely recognised. At this stage, we're not ruling anything out.